These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
615 related items for PubMed ID: 29680006
1. Treatment of refractory category III nonbacterial chronic prostatitis/chronic pelvic pain syndrome with intraprostatic injection of onabotulinumtoxinA: a prospective controlled study. Abdel-Meguid TA, Mosli HA, Farsi H, Alsayyad A, Tayib A, Sait M, Abdelsalam A. Can J Urol; 2018 Apr; 25(2):9273-9280. PubMed ID: 29680006 [Abstract] [Full Text] [Related]
2. Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome: results of a prospective pilot double-blind and randomized placebo-controlled study. Falahatkar S, Shahab E, Gholamjani Moghaddam K, Kazemnezhad E. BJU Int; 2015 Oct; 116(4):641-9. PubMed ID: 25307409 [Abstract] [Full Text] [Related]
3. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study. Iwamura H, Koie T, Soma O, Matsumoto T, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C. BMC Urol; 2015 Dec 07; 15():120. PubMed ID: 26643109 [Abstract] [Full Text] [Related]
4. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Mehik A, Alas P, Nickel JC, Sarpola A, Helström PJ. Urology; 2003 Sep 07; 62(3):425-9. PubMed ID: 12946740 [Abstract] [Full Text] [Related]
5. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome. Xia D, Wang P, Chen J, Wang S, Jiang H. Chin Med J (Engl); 2011 Jul 07; 124(14):2158-61. PubMed ID: 21933619 [Abstract] [Full Text] [Related]
7. Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study. Matsukawa Y, Naito Y, Funahashi Y, Ishida S, Fujita T, Tochigi K, Kato M, Gotoh M. Neurourol Urodyn; 2020 Sep 01; 39(7):1994-2002. PubMed ID: 32648985 [Abstract] [Full Text] [Related]
8. Comparison of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain syndrome: A randomized prospective trial. Sevim M, Alkiş O, Kartal İG, Kazan HO, İvelik Hİ, Aras B, Kabay Ş. Prostate; 2023 Jun 01; 83(8):751-758. PubMed ID: 36871235 [Abstract] [Full Text] [Related]
9. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. Nickel JC, Narayan P, McKay J, Doyle C. J Urol; 2004 Apr 01; 171(4):1594-7. PubMed ID: 15017228 [Abstract] [Full Text] [Related]
10. Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men. Walz J, Perrotte P, Hutterer G, Suardi N, Jeldres C, Bénard F, Valiquette L, Karakiewicz PI. BJU Int; 2007 Dec 01; 100(6):1307-11. PubMed ID: 17941922 [Abstract] [Full Text] [Related]
11. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. Nickel JC, Pontari M, Moon T, Gittelman M, Malek G, Farrington J, Pearson J, Krupa D, Bach M, Drisko J, Rofecoxib Prostatitis Investigator Team. J Urol; 2003 Apr 01; 169(4):1401-5. PubMed ID: 12629372 [Abstract] [Full Text] [Related]
12. National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. Wagenlehner FM, van Till JW, Magri V, Perletti G, Houbiers JG, Weidner W, Nickel JC. Eur Urol; 2013 May 01; 63(5):953-9. PubMed ID: 23141933 [Abstract] [Full Text] [Related]
13. Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome. Vicari E, Salemi M, Sidoti G, Malaguarnera M, Castiglione R. Nutrients; 2017 Nov 03; 9(11):. PubMed ID: 29099760 [Abstract] [Full Text] [Related]
14. Intraprostatic injection of botulinum toxin-A in patients with refractory chronic pelvic pain syndrome: The transurethral vs. transrectal approach. El-Enen MA, Abou-Farha M, El-Abd A, El-Tatawy H, Tawfik A, El-Abd S, Rashed M, El-Sharaby M. Arab J Urol; 2015 Jun 03; 13(2):94-9. PubMed ID: 26413328 [Abstract] [Full Text] [Related]
15. Chronic prostatitis/chronic pelvic pain syndrome: symptoms are aggravated by cold and become less distressing with age and time. Hedelin H, Jonsson K. Scand J Urol Nephrol; 2007 Jun 03; 41(6):516-20. PubMed ID: 17853027 [Abstract] [Full Text] [Related]
16. Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial. Zhang K, Liu Y, Yang W, Wang J, Yang J, Zhang G, Bai W, Chen S. Urology; 2021 Jul 03; 153():264-269. PubMed ID: 33482135 [Abstract] [Full Text] [Related]
17. Effect of Essential Oil on Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Pilot Randomized Controlled Trial. Ying J, Zhou MJ, Chen HY, Chen L, Zhang W, Ji J, Yu C, Zhang ZJ. Chin J Integr Med; 2019 Feb 03; 25(2):91-95. PubMed ID: 29948596 [Abstract] [Full Text] [Related]
18. Clinical study of duloxetine hydrochloride combined with doxazosin for the treatment of pain disorder in chronic prostatitis/chronic pelvic pain syndrome: An observational study. Zhang M, Li H, Ji Z, Dong D, Yan S. Medicine (Baltimore); 2017 Mar 03; 96(10):e6243. PubMed ID: 28272220 [Abstract] [Full Text] [Related]
19. Testosterone and Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Propensity Score-Matched Analysis. Lee JH, Lee SW. J Sex Med; 2016 Jul 03; 13(7):1047-55. PubMed ID: 27235281 [Abstract] [Full Text] [Related]
20. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN. J Urol; 2003 Feb 03; 169(2):592-6. PubMed ID: 12544314 [Abstract] [Full Text] [Related] Page: [Next] [New Search]